All Pharma News
Galderma Introduces High Potency Cetaphil Serums Designed for Sensitive Skin

Galderma Introduces High Potency Cetaphil Serums Designed for Sensitive Skin
BUSINESSWIRE
09 Jul 2024
Share Share
Galderma Granted Key Manufacturing License Updates

Galderma Granted Key Manufacturing License Updates
BUSINESSWIRE
19 Jun 2024
Share Share
Galderma Restylane® Volyme™ Launch: Fast-Growing China Aesthetics Market

Galderma Restylane® Volyme™ Launch: Fast-Growing China Aesthetics Market
BUSINESSWIRE
23 May 2024
Share Share
Galderma Filings For Nemolizumab In 4 More Countries

Galderma Filings For Nemolizumab In 4 More Countries
BUSINESSWIRE
07 May 2024
Share Share
Galderma Q1 Sales Top $1B, Up 12.4% YoY

Galderma Q1 Sales Top $1B, Up 12.4% YoY
BUSINESSWIRE
24 Apr 2024
Share Share
Galderma Announces Full Exercise of Over-Allotment Option

Galderma Announces Full Exercise of Over-Allotment Option
BUSINESSWIRE
26 Mar 2024
Share Share
Galderma Prices IPO at CHF 53 Per Share and Will Start Trading

Galderma Prices IPO at CHF 53 Per Share and Will Start Trading
BUSINESSWIRE
20 Mar 2024
Share Share
AMWC 2024: Galderma to Share New Data From Injectable Aesthetic Portfolio

AMWC 2024: Galderma to Share New Data From Injectable Aesthetic Portfolio
BUSINESSWIRE
19 Mar 2024
Share Share
Galderma kicks off the process for $2.6B IPO

Galderma kicks off the process for $2.6B IPO
Zoey Becker FIERCE PHARMA
13 Mar 2024
Share Share
Galderma Announces Intention to Float on the SIX Swiss Exchange

Galderma Announces Intention to Float on the SIX Swiss Exchange
BUSINESSWIRE
06 Mar 2024
Share Share